Acadia Healthcare Company, Inc.
ACHC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $852 | $869 | $771 | $774 |
| % Growth | -2% | 12.8% | -0.5% | – |
| Cost of Goods Sold | $30 | $29 | $519 | $29 |
| Gross Profit | $821 | $841 | $251 | $746 |
| % Margin | 96.4% | 96.7% | 32.6% | 96.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $525 | $515 | $46 | $485 |
| SG&A Expenses | $525 | $515 | $46 | $485 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $176 | $183 | $192 | $157 |
| Operating Expenses | $702 | $698 | $238 | $642 |
| Operating Income | $120 | $142 | $13 | $103 |
| % Margin | 14% | 16.4% | 1.7% | 13.4% |
| Other Income/Exp. Net | -$80 | -$92 | $0 | -$65 |
| Pre-Tax Income | $40 | $50 | $13 | $38 |
| Tax Expense | $2 | $12 | $4 | $4 |
| Net Income | $36 | $30 | $8 | $33 |
| % Margin | 4.3% | 3.5% | 1.1% | 4.2% |
| EPS | 0.4 | 0.33 | 0.09 | 0.36 |
| % Growth | 21.2% | 266.7% | -75% | – |
| EPS Diluted | 0.4 | 0.33 | 0.09 | 0.35 |
| Weighted Avg Shares Out | 90 | 90 | 92 | 92 |
| Weighted Avg Shares Out Dil | 91 | 90 | 92 | 92 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $37 | $35 | $29 | $30 |
| Depreciation & Amortization | $47 | $49 | $48 | $40 |
| EBITDA | $124 | $134 | $91 | $108 |
| % Margin | 14.6% | 15.4% | 11.8% | 13.9% |